Education for primary care : an official publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors·2020
Lung function in acute myeloid leukemia (AML) patients undergoing total body irradiation (TBI) and bone marrow transplantation (BMT) showed temporary decline post-procedure. Lung function improved after 100 days but did not fully recover pre-transplant levels.
Area of Science:
Hematology
Pulmonology
Oncology
Background:
Acute myeloid leukemia (AML) treatment often involves intensive regimens like total body irradiation (TBI) and bone marrow transplantation (BMT).
Pulmonary complications can significantly impact patient outcomes following TBI and BMT.
Purpose of the Study:
To prospectively evaluate lung function changes in AML patients post-TBI and BMT.
To identify factors associated with pulmonary complications after transplantation.
Main Methods:
Prospective lung function study of 48 AML patients treated with TBI and BMT.
Assessment of gas exchange, ventilatory defects, and diffusing capacity (DLCO) before and after transplantation.
Main Results:
Mildly impaired gas exchange was noted pre-transplant in some patients.
Progressive, subclinical lung function deterioration occurred within 100 days post-TBI/BMT.
Infection and graft-versus-host disease (GvHD) worsened lung function.
Ventilatory ability and gas transfer improved beyond 100 days but remained below pre-transplant levels.
No evidence of progressive pulmonary fibrosis was observed within the first year.
Conclusions:
TBI and BMT induce transient pulmonary changes in AML patients.
Pulmonary function recovery is incomplete, with GvHD and infection being significant complicating factors.
Long-term pulmonary fibrosis was not a major concern in this cohort within the first year.